News
The 18th Czech Annual Cancer Research Meeting has concluded with success!
The conference took place on November 20-22, 2023 in Olomouc, Czech Republic.
Preparatory meeting for the SALVAGE project
The meeting took place on November 20, 2023 as a part of the Czech Annual Cancer Research Meeting in Olomouc.
PERMED: T2BA Consortium meeting + T2BA Scientific Board meeting (NCC Council)
November 14–15, 2023 / Prague
IMTM YouTube channel
Featured publications
High speed of fork progression induces DNA replication stress and genomic instability.
Nature.
2018,
559(7713),
279-284,
ISSN: 0028-0836,
IF: 41.577,
PMID: 29950726.
Alcohol-abuse drug disulfiram targets cancer via p97 segregase adaptor NPL4.
Nature.
2017,
552(7684),
194-199,
ISSN: 0028-0836,
IF: 40.137,
PMID: 29211715.
Bridging the translational innovation gap through good biomarker practice.
Nature Reviews. Drug Discovery.
2017,
16(9),
587-588,
ISSN: 1474-1776,
IF: 57.000,
PMID: 28450744.
Putting translational science on to a global stage.
Nature Reviews Drug Discovery.
2016,
15,
217-219,
ISSN: 1474-1776,
IF: 57.000,
PMID: 27032820.
A Synergistic Interaction between Chk1-and MK2 Inhibitors in KRAS-Mutant Cancer.
Cell.
2015,
162(1),
146-159,
ISSN: 0092-8674,
IF: 28.710,
PMID: 26140595.
REV7 counteracts DNA double-strand break resection and affects PARP inhibition.
Nature.
2015,
521(7553),
541-544,
ISSN: 0028-0836,
IF: 38.138,
PMID: 25799992.